GE Healthcare Optima IGS 320
Medical device recall Z-0414-2016. Published in FDA’s Enforcement Report on Dec 23, 2015.
No Watch here, and no alerts: openFDA asks that its enforcement data “should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall” (openFDA). For FDA’s own recall emails, subscribe at FDA. FDA’s own record is on accessdata.fda.gov.
The short answer
Published in FDA’s Enforcement Report on Dec 23, 2015. Copied from openFDA on Oct 20, 2026.
- Class II FDA’s class
- Terminated its status, in FDA’s file
- Nationwide FDA’s word, and 19 states named
- 45 how much, in FDA’s words
Every line below is in FDA’s own words, with its source beside it. FDA’s terms are explained in FDA’s own words.
How serious is it, by FDA’s class?
Class II, the middle of FDA’s three classes.
“Products that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.”
openFDA, in plain words, its enforcement report fields.
“Class II is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
FDA’s rule, 21 CFR 7.3(m)(2), eCFR.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
What’s wrong with it?
GE Healthcare has recently become aware of a potential safety issue related to a non-recoverable loss of displayed imaging (loss of monitor video) involving Optima CL323i & Optima IGS 320 systems.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Which ones are recalled?
GE Healthcare Optima IGS 320. Product Usage: The angiographic X-ray systems are indicated for use for patients from newborn to geriatric in generating fluoroscopic and rotational images of human anatomy for cardiovascular, vascular and non-vascular, diagnostic and interventional procedures. Additionally, with the OR table, the angiographic X-ray systems are indicated for use in generating fluoroscopic and rotational images of human anatomy for image-guided surgical procedures. The OR table is suitable for interventional and surgical procedures.
45, in FDA’s words.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Codes to check against yours
00000116342HL7 BA4020VA03 00000127265HL7 XVV1S15019 00000124734HL5 XV124857HL4 00000121103HL6 HC1251XR03 00000102618HL6 083016020038813 00000128170HL8 083016061894915 00000115935HL9 083016100119314 00000125802HL9 083016200031715…
Every code shown here, 1,222 characters
00000116342HL7 BA4020VA03 00000127265HL7 XVV1S15019 00000124734HL5 XV124857HL4 00000121103HL6 HC1251XR03 00000102618HL6 083016020038813 00000128170HL8 083016061894915 00000115935HL9 083016100119314 00000125802HL9 083016200031715 00000123471HL5 083016208011415 00000118232HL8 083016240028414 00000122806HL3 083016247131115 00000112586HL3 083016280008314 00000119769HL8 083016284903114 00000122805HL5 083016287138315 00000114746HL1 083016289336814 00000116996HL0 083016601010614 00000112287HL8 083016801002714 00000108901HL0 083016801024714 00000122417HL9 083016807113615 00000109262HL6 083016807511514 00000123932HL6 083016809698915 00000119571HL8 083016824740714 00000110467HL8 083016846514214 00000104227HL4 083016860037213 00000125616HL3 083016860528415 00000113585HL4 083016861004214 00000128059HL3 083016862769215 00000126960HL4 083016029472715 00000120518HL5 083016866085914 00000120528HL5 GON4260859 00000010594HL3 083016844488913 00000105944HL3 GON4144889 00000129362HL0 0004344218 00000122667HL9 5512XR0010 00000124068HL8 5512XR0032 00000124830HL1 5512XR0033 00000124904HL4 5512XR0025 00000125415HL0 5512XR0034 00000129237HL4 GON4344915 00000115056HL4 PL3480VA01 00000128693HL9 1573XR0032 00000121982HL3 42026VAS01
Copied exactly as FDA lists them: lot and serial numbers, dates and other codes on the product or its label.
Where did it go?
FDA’s words for the “general area of initial distribution”: where the firm first shipped it.
Worldwide Distribution - US Nationwide in the states of: AR, AZ, DC, FL, GA, IL, IN, LA, MI, NC, NE, NJ, NV, NY, OH, SC, TN, TX, WA. and the countries of Algeria, Bangladesh, Bosnia and Herzegovina, Brazil, China, Dominican Republic, Ethiopia, Georgia, Germany, India, Indonesia, Italy, Lebanon Martinique , Morocco, Poland, Republic of Moldova, Russia, Spain Thailand, Trinidad, Turkey, and Uzbekistan.
The states and territories these words name
19 states and territories.
Every one of them
- Arkansas
- Arizona
- District of Columbia
- Florida
- Georgia
- Illinois
- Indiana
- Louisiana
- Michigan
- North Carolina
- Nebraska
- New Jersey
- Nevada
- New York
- Ohio
- South Carolina
- Tennessee
- Texas
- Washington
What FDA means by nationwide
“The term “nationwide” is defined to mean the fifty states or a significant portion. Note that subsequent distribution by the consignees to other parties may not be included.”
openFDA, its enforcement report fields.
The words say it went outside the United States too.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
Is it still going on?
Terminated, in FDA’s file.
“FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.”
openFDA, on “Terminated”, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
- The firm began the recall on Nov 13, 2015.
- FDA classified it on Dec 12, 2015.
- FDA’s Enforcement Report published it on Dec 23, 2015.
- FDA terminated it on Sep 7, 2016.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Who is recalling it?
- GE Medical Systems, LLC, of Waukesha, WI.
- Who began it, in FDA’s words: Voluntary: Firm initiated.
- How the firm first told its customers: Letter.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
What this record can’t tell you
- Whether your own one is affected: compare the codes, dates and numbers above with yours. When unsure, ask the firm or the store.
- Where it went after the firm’s first shipments. FDA’s words cover the firm’s initial distribution, and, in FDA’s words, “subsequent distribution by the consignees to other parties may not be included.”
- How many have been returned, corrected or destroyed: FDA’s report doesn’t say.
- Whether anyone was hurt or fell ill: the report doesn’t say.
- How current it is: openFDA publishes FDA’s Enforcement Report weekly, after FDA does, and a firm can announce a recall weeks before it appears there. openFDA’s own caution: “This data should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall.”
- A product with no recall here isn’t safe by that: FDA’s report lists the recalls FDA classified, and when.
Hearth Record wrote these lines; the quotations are FDA’s.
Sources
-
U.S. Food and Drug Administration, Device recall enforcement reports.
Released Oct 14, 2026 and checked Oct 20, 2026. Updated weekly. Public domain (CC0 1.0, openFDA). FDA asks that nothing suggest it endorses this site.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.” Copied on Oct 20, 2026.